Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs RxPros

PlexusDx
Graded #162

Lower grade

vs+1.3999999999999915
RxPros
Graded #138

Higher grade

The verdict

RxPros takes it — 69.1/100 to 67.7/100, but only just.

RxPros grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxPros (rxpros.com) is a Wyoming-incorporated compounded GLP-1 telehealth platform (RxPros LLC, 1309 Coffeen Ave Ste 15880, Sheridan, WY 82801). PlexusDx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +4
74
70
Dose & formulationEven
64
64
Clinical oversightRxPros +17
74
91
Labs & monitoringRxPros +1
52
53
FulfillmentPlexusDx +4
78
74
Contract termsPlexusDx +8
55
47
PlexusDx · left barRxPros · right bar

The numbers

MetricPlexusDxRxPros
WeighScore67.7/10069.1/100
GradeCC
Scorecard rank#162#138
Semaglutide$149/mo (starting dose, compounded)$100/mo (annual plan, compounded)
Tirzepatide$249/mo (starting dose, compounded)$145/mo (annual plan, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #162 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
RxPros

Graded #138 · C

Strengths

  • $99.99/month compounded semaglutide — among the cheapest in the US compounded telehealth market
  • $144.97/month compounded tirzepatide — at the lower end of the compounded tirzepatide range
  • LegitScript Certified
  • Named legal entity (RxPros LLC) with a physical Wyoming address
  • Overnight cold-packed shipping disclosed — important for GLP-1 cold-chain integrity

Where it loses points

  • Per-state availability not listed — verify your state ships before committing
  • Specific 503A pharmacy partners not named
  • Lab work not included as standard
  • LegitScript certification number not displayed (seal only)
  • Lowest headline prices ($99.99 sema / $144.97 tirz) require annual prepay; intro-first-month/quarterly tier is $134.99 sema / $224.99 tirz

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard